Hemostasis Testing Systems MarketThe global hemostasis testing systems market value is likely to jump from US$ 2,149.3 million in 2023 to US$ 3,666 million by 2033. This is expected to be driven by a steady CAGR of 5.5% in the hemostasis testing systems market over the next decade.The market is driven by the increas.
Seeking satiety: From signals to solutions science.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from science.org Daily Mail and Mail on Sunday newspapers.
Durin Technologies, Inc , Appoints CEO streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
"The major players operating in this market are F. Hoffmann-La Roche Ltd. (Switzerland), Grifols (Spain), Abbott Laboratories, Inc. (US), Bio-Rad Laboratories, Inc. (US), Danaher (Beckman Coulter, Inc.) (US), bioMérieux